IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Molecular Therapy - Nucleic Acids

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

8.55

h-Index

2022-2023

 84

Rank

2022-2023

 1389

SJR

2022-2023

 1.947

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Molecular Therapy - Nucleic Acids
Abbreviation Mol. Ther. - Nucleic Acids
Publication Type Journal
Subject Area, Categories, Scope Drug Discovery (Q1); Molecular Medicine (Q1)
h-index 84
Overall Rank/Ranking 1389
SCImago Journal Rank (SJR) 1.947
Impact Score 8.55
Publisher Cell Press
Country United States
ISSN 21622531
Best Quartile Q1
Coverage History 2012-2022




About Molecular Therapy - Nucleic Acids


Molecular Therapy - Nucleic Acids is a journal covering the technologies/fields/categories related to Drug Discovery (Q1); Molecular Medicine (Q1). It is published by Cell Press. The overall rank of Molecular Therapy - Nucleic Acids is 1389. According to SCImago Journal Rank (SJR), this journal is ranked 1.947. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 84. The best quartile for this journal is Q1.

The ISSN of Molecular Therapy - Nucleic Acids journal is 21622531. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Therapy - Nucleic Acids is cited by a total of 8600 articles during the last 3 years (Preceding 2022).


Molecular Therapy - Nucleic Acids Impact IF 2022-2023


The Impact IF 2022 of Molecular Therapy - Nucleic Acids is 8.55, which is computed in 2023 as per its definition. Molecular Therapy - Nucleic Acids IF is decreased by a factor of 0.99 and approximate percentage change is -10.38% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Molecular Therapy - Nucleic Acids Impact IF 2023 Prediction


Impact IF 2022 of Molecular Therapy - Nucleic Acids is 8.55. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Molecular Therapy - Nucleic Acids. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 8.55
2021 9.54
2020 8.00
2019 6.99
2018 5.53
2017 5.28
2016 6.98
2015 5.49
2014 4.68

Molecular Therapy - Nucleic Acids h-index


  Table Setting

Molecular Therapy - Nucleic Acids has an h-index of 84. It means 84 articles of this journal have more than 84 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Molecular Therapy - Nucleic Acids ISSN


The ISSN of Molecular Therapy - Nucleic Acids is 21622531. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Molecular Therapy - Nucleic Acids Rank and SCImago Journal Rank (SJR)


The overall rank of Molecular Therapy - Nucleic Acids is 1389. According to SCImago Journal Rank (SJR), this journal is ranked 1.947. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Molecular Therapy - Nucleic Acids by Year


Year SJR
2023/2024 Coming Soon
2022 1.947
2021 1.852
2020 2.208
2019 2.089
2018 2.011
2017 2.523
2016 2.795
2015 2.308
2014 1.727

Ranking of Molecular Therapy - Nucleic Acids by Year


Year Ranking
2023/2024 Coming Soon
2022 1389
2021 1424
2020 1120
2019 1219
2018 1358
2017 909
2016 738
2015 1097
2014 1817

Molecular Therapy - Nucleic Acids Publisher


Table Setting

Molecular Therapy - Nucleic Acids is published by Cell Press. It's publishing house is located in United States. Coverage history of this journal is as following: 2012-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Molecular Therapy - Nucleic Acids is Mol. Ther. - Nucleic Acids. This abbreviation ('Mol. Ther. - Nucleic Acids') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Molecular Therapy - Nucleic Acids


If your research field is/are related to Drug Discovery (Q1); Molecular Medicine (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Molecular Therapy - Nucleic Acids?

Molecular Therapy - Nucleic Acids latest impact IF is 8.55. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 9.54 (2021) and 4.68 (2014), respectively, in the last 9 years. Moreover, its average IS is 6.78 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Molecular Therapy - Nucleic Acids?

The Molecular Therapy - Nucleic Acids has an SJR (SCImago Journal Rank) of 1.947, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.795 in 2016 and the lowest being 1.727 in 2014. Furthermore, the average SJR of the Molecular Therapy - Nucleic Acids over the previous 9-year period stands at 6.78.


What's the latest h-index of the Molecular Therapy - Nucleic Acids?

The latest h-index of the Molecular Therapy - Nucleic Acids is 84.


Who's the publisher of the Molecular Therapy - Nucleic Acids?

The Molecular Therapy - Nucleic Acids is published by the Cell Press, with its country of publication being the United States.


What's the current ranking of the Molecular Therapy - Nucleic Acids?

The Molecular Therapy - Nucleic Acids is currently ranked 1389 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 738 in 2016 and its lowest position of 1817 in 2014.


What's the abbreviation or short name for the Molecular Therapy - Nucleic Acids?

The standard ISO4 abbreviation for the Molecular Therapy - Nucleic Acids is Mol. Ther. - Nucleic Acids.


Is the "Molecular Therapy - Nucleic Acids" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Molecular Therapy - Nucleic Acids is classified as a journal that the Cell Press publishes.


What's the scope or major areas of the Molecular Therapy - Nucleic Acids?

The Molecular Therapy - Nucleic Acids encompasses the following areas:

  • Drug Discovery
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Molecular Therapy - Nucleic Acids?

The Molecular Therapy - Nucleic Acids is assigned the following International Standard Serial Numbers (ISSN): 21622531.


What's the best quartile of the Molecular Therapy - Nucleic Acids?

The best quartile for the Molecular Therapy - Nucleic Acids is Q1 (2022).


What's the coverage history of the Molecular Therapy - Nucleic Acids?

The Molecular Therapy - Nucleic Acids coverage history can be summarized as follows: 2012-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Business: Theory and Practice journal 13414 Vilnius Gediminas Technical University 21 2.47
Discourse journal 6621 Routledge 59 2.11
World Englishes journal 4960 Wiley-Blackwell 60 1.97
International Journal of Parallel, Emergent and Distributed Systems journal 15843 Taylor and Francis Ltd. 23 1.28
Indian Phytopathology journal 14222 Springer Nature 11 1.33
Biological Procedures Online journal 3350 BioMed Central Ltd. 43 6.40
Engenharia Agricola journal 15839 Sociedade Brasileira de Engenharia Agricola 30 1.12
Rudarsko Geolosko Naftni Zbornik journal 14294 University of Zagreb, Faculty of Mining, Geology and Petroleum Engineering 17 1.48
Transactions on Embedded Computing Systems journal 6019 Association for Computing Machinery (ACM) 61 2.25
English Literary Renaissance journal 23442 University of Chicago Press 20 0.25

Check complete list




Year wise Impact Score (IS) of Molecular Therapy - Nucleic Acids

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 8.55
2021 9.54
2020 8.00
2019 6.99
2018 5.53
2017 5.28
2016 6.98
2015 5.49
2014 4.68



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

See All